Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02598453 · ClinicalTrials.gov registry record · Phase 4

PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia

A Phase 4 study of Postmenopausal Osteoporosis, sponsored by Hoffmann-La Roche.

Completed
Registry status
Phase 4
Development phase
545
Enrollment target
20
Study locations

NCT02598453 is a Phase 4 study of Postmenopausal Osteoporosis that has completed, run by Hoffmann-La Roche. The registered enrollment target is 545 participants, roughly in line with the 541-participant average among 12 other Postmenopausal Osteoporosis trials with a reported enrollment target. The trial reports 20 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02598453, a Phase 4 study of Postmenopausal Osteoporosis, has completed, sponsored by Hoffmann-La Roche.

COMPLETED
Registry status
Phase 4
Development phase
545 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to evaluate treatment adherence to different regimens of ibandronate in postmenopausal women with osteoporosis or osteopenia who are intolerant to daily or weekly alendronate or risedronate therapy due to gastrointestinal (GI) side effects. The anticipated time on study treatment is 12 months, and the target sample size is 517 individuals.

Conditions Studied

Postmenopausal Osteoporosis

Interventions

  • DRUG Ibandronate

Study Locations (20)

Florida

  • - Beverly Hills
  • - Fort Myers
  • - Gainesville
  • - Miami
  • - Ocala
  • - Palm Harbor
  • - West Palm Beach

California

  • - San Diego
  • - San Diego
  • - Santa Monica
  • - Tacoma
  • - Vista

Arizona

  • - Lake Havasu City
  • - Paradise Valley

Alabama

  • - Montgomery

Arkansas

  • - Pine Bluff

Georgia

  • - Augusta

Idaho

  • - Coeur d'Alene

Illinois

  • - Champaign

Trial Details

FieldValue
Enrollment Target 545 participants
Start Date 2005-01
Est. Completion 2006-09
Phase Phase 4

Sponsor

Hoffmann-La Roche

909 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02598453

The ClinicalTrials.gov registry entry for NCT02598453 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 545 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 541-participant average among 12 other Postmenopausal Osteoporosis trials with a reported enrollment target. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postmenopausal Osteoporosis appearing as the primary indexed condition, and to 1 intervention - of which Ibandronate is the first listed.

NCT02598453 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Florida, California, Arizona.

Frequently Asked Questions

What is clinical trial NCT02598453 about?

NCT02598453 is a clinical study titled "PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia". The purpose of this study is to evaluate treatment adherence to different regimens of ibandronate in postmenopausal women with osteoporosis or osteopenia who are intolerant to daily or weekly alendronate or risedronate therapy due to gastrointestinal (GI) side effects. The anticipated time on study ...

What is the current status of trial NCT02598453?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 545 participants. The study started on 2005-01. Estimated completion is 2006-09.

What conditions does trial NCT02598453 study?

This clinical trial studies the following conditions: Postmenopausal Osteoporosis.

What interventions are being tested in trial NCT02598453?

The interventions under investigation include: Ibandronate (DRUG).

Who is sponsoring clinical trial NCT02598453?

This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02598453 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Postmenopausal Osteoporosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Postmenopausal Osteoporosis

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.